Michael Schultz

Session 2: PLENARY/BUSHELL
(Sun 10:30 – 12:30 Arena 1B)
Presentation Title: Trans-Tasman Lecture – Colonic Organoids – Mini Guts to Study the Intestinal Epithelium in IBD
11:50 – 12:10
click here to view session

Session 4: Looking into the future in IBD
(Tue 16:00 – 17:30 Central A)
Presentation Title: Digital technologies to Deliver Quality IBD Care
16:13 – 16:26
click here to view session


Associate Professor Michael Schultz
MD, PhD, FRACP

Michael studied in Erlangen-Nuremberg, Germany and trained in Manchester, London and Regensburg, Germany. He went to Chapel Hill, NC at the University of North Carolina for his postdoctoral fellowship investigating the role of commensal intestinal bacteria in the development of experimental colitis in the laboratory of Professor B Sartor. He completed his Habilitation on the topic of ‘Probiotc Mechanisms’ in 2004.

Michael joined the Department of Medicine at the University of Otago in 2005 taking up a joint clinical position as a Senior Lecturer, and Gastroenterologist with the Southern District Health Board. He was promoted to Associate Professor in 2013 and appointed Head of the Department of Medicine in 2016.

His research expertise is focused on clinical and basic scientific aspects of Inflammatory Bowel Diseases with an emphasis on host-microbe interactions and the epithelial barrier function. He has several years of experience working with animal models of experimental colitis and the administration of clinical trials in patients with IBD. He is Director of the Gut Health Network which was established as a research theme in 2011 and member of the steering committee of the ANZ IBD consortium. Lately, his focus has shifted to health delivery using digital technology.

Michael was elected as the President of the New Zealand Society of Gastroenterology in November 2016.


Back to speakers